Insights

Strategic Acquisition The recent acquisition by Eurofins Discovery enhances CALIXAR's market reach and resource capabilities, presenting opportunities for cross-selling sophisticated membrane protein solutions and integrated drug discovery services to a broader client base.

Innovative Platform CALIXAR's cutting-edge technology for isolating and crystallizing native full-length membrane proteins offers pharma and biotech companies high-fidelity targets for structure-based drug design, potentially increasing demand for their specialized services.

Expanding Product Offerings The launch of the Scientist.com Product Hub Marketplace enables CALIXAR to access new distribution channels, facilitating expanded sales of their membrane protein products to well-aligned biotech and research organizations globally.

Industry Collaborations Partnerships with distributors like CliniSciences, BioD, and AFS BioOil indicate strong regional outreach and collaborative opportunities for tailored solutions, opening avenues for customized service proposals to various pharma and research clients.

Growth Potential Despite current revenue levels, CALIXAR's high-value specialized services targeting membrane proteins and structure-based drug design position it as a promising partner for pharmaceutical firms seeking high-quality, structurally intact targets for innovative therapies.

CALIXAR Tech Stack

CALIXAR uses 8 technology products and services including React, jQuery Migrate, Swiper, and more. Explore CALIXAR's tech stack below.

  • React
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • Swiper
    Javascript Libraries
  • HubSpot
    Marketing Automation
  • Cloudflare Bot Management
    Security
  • X-Content-Type-Options
    Web & Portal Technology
  • HTTP/3
    Web & Portal Technology
  • LiteSpeed
    Web Servers

CALIXAR's Email Address Formats

CALIXAR uses at least 1 format(s):
CALIXAR Email FormatsExamplePercentage
FLast@calixar.comJDoe@calixar.com
47%
LastFir@calixar.comDoeJoh@calixar.com
3%
FLast@calixar.comJDoe@calixar.com
47%
LastFir@calixar.comDoeJoh@calixar.com
3%

Frequently Asked Questions

Where is CALIXAR's headquarters located?

Minus sign iconPlus sign icon
CALIXAR's main headquarters is located at 60 Avenue Rockefeller Lyon, Auvergne-rhone-alpes 69008 France. The company has employees across 1 continents, including Europe.

What is CALIXAR's phone number?

Minus sign iconPlus sign icon
You can contact CALIXAR's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is CALIXAR's official website and social media links?

Minus sign iconPlus sign icon
CALIXAR's official website is calixar.com and has social profiles on LinkedInCrunchbase.

What is CALIXAR's SIC code NAICS code?

Minus sign iconPlus sign icon
CALIXAR's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CALIXAR have currently?

Minus sign iconPlus sign icon
As of February 2026, CALIXAR has approximately 11 employees across 1 continents, including Europe. Key team members include Co-Founder Of The Calixar Company: P. F.Marketing Director, Europe: G. D.Scientific Director: K. K.. Explore CALIXAR's employee directory with LeadIQ.

What industry does CALIXAR belong to?

Minus sign iconPlus sign icon
CALIXAR operates in the Biotechnology Research industry.

What technology does CALIXAR use?

Minus sign iconPlus sign icon
CALIXAR's tech stack includes ReactjQuery MigrateSwiperHubSpotCloudflare Bot ManagementX-Content-Type-OptionsHTTP/3LiteSpeed.

What is CALIXAR's email format?

Minus sign iconPlus sign icon
CALIXAR's email format typically follows the pattern of FLast@calixar.com. Find more CALIXAR email formats with LeadIQ.

How much funding has CALIXAR raised to date?

Minus sign iconPlus sign icon
As of February 2026, CALIXAR has raised $1.1M in funding. The last funding round occurred on Feb 24, 2015 for $1.1M.

When was CALIXAR founded?

Minus sign iconPlus sign icon
CALIXAR was founded in 2011.

CALIXAR

Biotechnology ResearchAuvergne-rhone-alpes, France11-50 Employees

To contact us : contact@calixar.com
CALIXAR, is a biotech company specialized in the functional and native isolation of complex membrane therapeutic targets and antigens.
We develop and implement chemistry and biochemistry tools to isolate in solution - with the highest purity levels - full-length membrane proteins, while keeping their structural and functional integrity. Our approach represents the opportunity for pharmaceutical companies to start and work with high quality targets or antigens before developing antibodies, formulating vaccines and/or discovering a primary lead through Structure Based Drug Design or High Throughput Screening assays.
As membrane proteins represent more than 60% of pharmaceutical drug targets, to keep their native conformation during the extraction from membrane cells and solubilization is crucial.
Our technological platform preserves the original structure of membrane proteins  such as GPCRs, Ion channels, Transporters, Viral targets,  etc.) or others native receptors acting as drug targets or antigens. As a result, this most accurate targeting helps biotechs, academic teams, pharmaceutical industries to develop highly potential drugs, bio drugs and vaccines and consequently saves significant time and money in further clinical stages.
By using original chemistry and specific approaches designed on demand, we develop new tools and protocols for the identification, expression, extraction, purification and crystallization of these membrane proteins/antigens from cells or from endogenous materials (virus, bacteria, primary cells, organs, etc.).
For SBDD/FBDD approaches, we carry out crystallization tests and structure determination of these native targets starting from their full-length and functional version without any point mutations or deletions.
CALIXAR sets up specific R&D programs with its customers using classical and flexible business model: Fee for service, Risk sharing, Exclusivity option and Licensing out.

Section iconCompany Overview

Headquarters
60 Avenue Rockefeller Lyon, Auvergne-rhone-alpes 69008 France
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
11-50

Section iconFunding & Financials

  • $1.1M

    CALIXAR has raised a total of $1.1M of funding over 2 rounds. Their latest funding round was raised on Feb 24, 2015 in the amount of $1.1M.

  • $1M

    CALIXAR's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1.1M

    CALIXAR has raised a total of $1.1M of funding over 2 rounds. Their latest funding round was raised on Feb 24, 2015 in the amount of $1.1M.

  • $1M

    CALIXAR's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.